Recent progress in optimizing radiotherapy in chemo-radiotherapy for stage III non-small cell lung cancer

作者: Noah C. Choi , Rafael Rosell

DOI: 10.1007/BF02711634

关键词:

摘要: It is logical to tailor radiation dose schedule according the therapeutic goals, i.e., curative versus pal-liative achieve best possible outcome for a given clinical condition. Not all patients with stage III served optimally by administering same of or chemo-radiotherapy regimen. The aim this study update recent progress in research escalation dose/dose intensity and radiotherapeutic/predictive factors response which may be useful guiding high therapy chemo-radiation (CT+RT) beter outcome.

参考文章(98)
H. J. Altermatt, N. Thatcher, J. Heighway, W. D. J. Ryder, D. C. Betticher, P. Hoban, Alternate splicing produces a novel cyclin D1 transcript. Oncogene. ,vol. 11, pp. 1005- 1011 ,(1995)
Wei Zhou, Gennaro Galizia, Steven N. Goodman, Katharine E. Romans, Kenneth W. Kinzler, Bert Vogelstein, Michael A. Choti, Elizabeth A. Montgomery, Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nature Biotechnology. ,vol. 19, pp. 78- 81 ,(2001) , 10.1038/83572
Timothy W. Synold, Isabelle Dussault, Barry Marc Forman, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Medicine. ,vol. 7, pp. 584- 590 ,(2001) , 10.1038/87912
Huilin Zhou, Julian D. Watts, Ruedi Aebersold, A systematic approach to the analysis of protein phosphorylation Nature Biotechnology. ,vol. 19, pp. 375- 378 ,(2001) , 10.1038/86777
James Suen, Vaneerat Ratanatharathorn, Ehab Hanna, Randy Breau, Dennis C. Shrieve, Xueqing Xia, Shulin Li, A Novel Alternative Approach for Prediction of Radiation Response of Squamous Cell Carcinoma of Head and Neck Cancer Research. ,vol. 61, pp. 2376- 2380 ,(2001)
D Gibson, A Harvey, S Dische, MI Saunders, A Barret, Mkb Parmar, Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: An interim report Cancer/Radiotherapie , 1 (3) pp. 263-264. (1997). ,(1997)
Mariano Monzó, Rafael Rosell, José Javier Sánchez, Jin S. Lee, Aurora O'Brate, José Luis González-Larriba, Vicente Alberola, Juan Carlos Lorenzo, Laura Núñez, Jae Y. Ro, Cristina Martín, Paclitaxel Resistance in Non–Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations Journal of Clinical Oncology. ,vol. 17, pp. 1786- 1793 ,(1999) , 10.1200/JCO.1999.17.6.1786
H J Lenz, C G Leichman, K D Danenberg, P V Danenberg, S Groshen, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, Y Garcia, J Li, L Leichman, Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. Journal of Clinical Oncology. ,vol. 14, pp. 176- 182 ,(1996) , 10.1200/JCO.1996.14.1.176
James A. Hayman, Mary K. Martel, Randall K. Ten Haken, Daniel P. Normolle, Robert F. Todd, J. Fred Littles, Molly A. Sullivan, Peter W. Possert, Andrew T. Turrisi, Allen S. Lichter, Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial Journal of Clinical Oncology. ,vol. 19, pp. 127- 136 ,(2001) , 10.1200/JCO.2001.19.1.127
R Metzger, C G Leichman, K D Danenberg, P V Danenberg, H J Lenz, K Hayashi, S Groshen, D Salonga, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, B Konda, L Leichman, ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. Journal of Clinical Oncology. ,vol. 16, pp. 309- 316 ,(1998) , 10.1200/JCO.1998.16.1.309